Research in the Department of Pathology
Our innovative research programs in Pathology bridge multiple disciplines to pursue both fundamental and translational research. Our goals are to understand the basic molecular, cellular, and physiological mechanisms of disease and to continually translate our findings into improved patient care.
The fields of molecular pathology and diagnostics are being transformed by our researchers, whose investigations focus on unraveling the mechanisms of cancer progression and etiology of inflammatory and degenerative diseases. Strongest areas of expertise are: molecular biology, cell biology, genetics, virology, and vascular biology.
Pathology Research Faculty
Pathology Research Laboratories
Office of Research Affairs
The Yale Pathology Office of Research Affairs partners with faculty members, multidisciplinary teams, and institutional resources to advance the strategic priorities of the Department of Pathology to facilitate basic, clinical, and translational research activities, and enhance competitiveness for extramural research funding.
Pathology Informatics
Yale Pathology Informatics Program is dedicated to providing our pathologists and researchers a way integrate detailed clinical information into evidence-based, patient-specific diagnostic and treatment decisions. This involves designing, building, deploying, and maintaining information management solutions and displaying the data to advance the day-to-day practice of pathology.
Yale Pathology Tissue Services - YPTS
This program provides cutting edge tissue-related services to our researchers to enable their investigations in biology, therapeutics, and clinical trials.
Yale Center For Research on Aging
- July 16, 2024
YCC 2024 Trainee Colloquium
- July 11, 2024
Research Reveals Potential Target for Immune Diseases
- July 11, 2024
Can AI Help Predict Alzheimer’s, Cancer? Study Targets Telltale Immune Changes
- July 11, 2024Source: Yale Ventures
11 Yale Projects Receive Awards from the Colton Center for Autoimmunity
- July 09, 2024
Immunotherapy for NSCLC: Potential Biomarkers for Resistance Are Identified
- July 09, 2024
Yale Researchers Pave Way To Target Autoimmune Disease-Associated Gene Variant